Zwiers integrates regulatory intelligence information and health authority requirements into sound strategy, ensuring that requirements in the complex regulatory framework will be met.
Defining the right strategy is a matter of obtaining the relevant information, analysing and interpreting it and ensuring incorporation in project management planning. We do it for you; we’re good at it!
Meet with Zwiers! Contact us
Zwiers Regulatory Consultancy maintains the product lifecycle. From the very start until well after approval.
Coordination is key! Executing regulatory goals and fulfilling requirements can put a large burden on your resources. We reduce this burden by taking over all activities and handling regulatory procedures.
Meet with Zwiers! Contact us
(e)CTA? eIND? IMPD? eCTD for new NDA/BLA/MAA? for variation/extension/supplement?
We make sure you’re submission ready! We write, review, hyperlink, QC, compile and submit in line with regulatory guidelines.
All meetings – e.g. scientific advice, pre-IND, EOP, pre-submission – with regulatory health authorities require preparation, whether they are of a scientific or a regulatory nature, with a national or a central agency and regardless of the product lifecycle phase.
We provide:
We help decide on the strategy of approaching regulatory health authorities and which questions to ask
We compile meeting packages including writing of all necessary documentation
We train your meeting delegates to ask the right questions and to obtain relevant answers
We use our regulatory expertise to interpret regulatory health authority requests and adequately address them in a timely manner. If you need our help with any of the above, please contact us
SPC, CCDS, PIL? An efficient Labelling Officer with writing and organisational skills will deliver compliant texts in time.
Do you have a promising compound ready for development?
Do your shareholders want to see a sound plan to bring it to the market?
Zwiers Regulatory Consultancy takes a special interest in helping start ups to increase chances of success.
We will discuss regulatory possibilities and challenges with you and present the results in a regulatory strategy plan. As discussions with the health authorities will also play an important part in the strategy, we will advise on when and how to approach health authorities.
Your drug in development may be very promising. You may be using a highly innovative technology. You may intend to serve a specific population. Or to treat a neglected or rare disease. Or maybe your product is in another way distinctively different from regular therapies. Because of its unique profile, the regular regulatory guidance may not apply or there may be a smart marketing authorization route. We will explore alternative pathways for you.
Examples are:
Not only do we provide you with strategic advice, we actually execute the plan. We prepare all documentation, e.g. clinical trial applications, target product profiles, requests for specific procedures, meeting packages and, ultimately, the application dossiers.
Please contact us.